Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909686 · ClinicalTrials.gov registry record · NA
Effects of Botanical Microglia Modulators in Gulf War Illness
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02909686: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02909686 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909686, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The overall objective of this protocol is to test if Gulf War Illness (GWI) involves chronic inflammation that cannot be measured with typical techniques. The investigators will be observing the effects of nine different botanical compounds (supplements) that are known to suppress inflammation. If one of those supplements helps the symptoms of GWI, it will give the investigators information about what is wrong in people with GWI.
Primary Outcome
Self reported Gulf War Illness symptom severity evening reports were collected for the duration of the study. Scale= change from baseline in overall GWI Disease severity (-100 to +100, with positive numbers indicating how much the symptom improved).
Interventions
- DIETARY_SUPPLEMENT Curcumin
- DIETARY_SUPPLEMENT Fisetin
- DIETARY_SUPPLEMENT Luteolin
- DIETARY_SUPPLEMENT Boswellia Serrata
- DIETARY_SUPPLEMENT Epimedium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-07 |
| Est. Completion | 2022-09 |
| Phase | NA |
What the finished NCT02909686 record still lists
NCT02909686 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Curcumin is the first listed.
NCT02909686 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02909686 about?
NCT02909686 is a clinical study titled "Effects of Botanical Microglia Modulators in Gulf War Illness". The overall objective of this protocol is to test if Gulf War Illness (GWI) involves chronic inflammation that cannot be measured with typical techniques. The investigators will be observing the effects of nine different botanical compounds (supplements) that are known to suppress inflammation. If o...
What is the current status of trial NCT02909686?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2016-07. Estimated completion is 2022-09.
What interventions are being tested in trial NCT02909686?
The interventions under investigation include: Curcumin (DIETARY_SUPPLEMENT), Fisetin (DIETARY_SUPPLEMENT), Luteolin (DIETARY_SUPPLEMENT), Boswellia Serrata (DIETARY_SUPPLEMENT), Epimedium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02909686?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02909686's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia